There is provided a series of novel α-(N-sulfonamido)acetamide compounds of the Formula (I) wherein R1, R.2 and n are defined herein, which are inhibitors of ß-amyloid peptide (ß-AP) production and are useful in the treatment of Alzheimer"s Disease and other conditions affected by anti-amyloid activity.